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Abstract: Economic uncertainty surrounds the distribution of Raboral V-RG7 as an oral rabies
vaccine (ORV) bait for the containment or elimination of raccoon-variant rabies in the United States.
This paper describes a costs-savings model of ORV. It also describes Excel XP7 code that was
prepared to compute potential net savings (NS) and benefit-cost ratios (BCRs) associated with
Raboral V-RG7 bait distributions. Currently, baits and bait distributions are relatively expensive;
individual baits are produced at a cost of $1.27 for federal use and typically dispensed at >75
baits/km2. Distribution is estimated at $8.62/km2, $15.80/km2, and $33.30/km2 for fixed-winged
(FW), ground (Gnd), and rotary-winged (RW) applications, respectively. Although many
assumptions are required, iterative runs of the code allow plotting NS and BCR response surfaces for
diverse scenarios based on 6 ORV variables: area (km2), bait-price (US$/vaccine bait), bait-density
(#/km2), application frequency (n), mode-of-delivery [$US for % fixed-winged (FW), % rotarywinged (RW), and % ground-dispensed (Gnd)], and effectiveness (% seropositive titer conversion).
Using a raccoon-rabies-epizootic-containment scenario for parts of Pennsylvania and a modest
epizootic cost estimate of $40 million, the greatest NS ($6.4 to 38.4 million) and BCR (2.85 to
25.76) indices occurred for a one-time bait distribution involving FW aircraft over a fourth of the
state with a $0.90/bait price. As expected, greater reliance on the more expensive RW and Gnd
modes of bait distribution compared to FW aircraft, coupled with higher bait prices and higher bait
densities, decreased NS and BCR indices. The utility of the approach to economic forecasting and
decision making of ORV effects are discussed.
Key words: direct costs, economics, oral vaccination, Procyon lotor, rabies, raccoon, uncertainty
Proceedings of the 10th Wildlife Damage
Management Conference. (K.A. Fagerstone,
G.W. Witmer, Eds). 2003

(Farneyhough et al. 1998; MacInnes et al.
2001). Currently, raccoon variant rabies is
enzootic, or likely to become enzootic, in 19
Eastern states (i.e., Alabama, Connecticut,
Delaware, Florida, Georgia, Maine, Maryland,
Massachusetts, New Hampshire, New Jersey,

INTRODUCTION
Oral wildlife vaccines have been
effective in limiting or eliminating coyote
(Canis latrans) and red fox (Vulpes vulpes)
transmitted rabies in areas of North America
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expected), allowed plotting numerous NS and
BCR outputs for a range of inputsBthe
response surfaces of these indices. The
approach afforded useful simulations of
potential benefits and costs linked with the
products.
Here, we present a cost-savings model
for using ORV to contain raccoon-variant
rabies. We then describe Excel XP7 code
(Microsoft7 Corp., Richmond, Washington,
USA) that was prepared to estimate NS and
BCR indices associated with key factors
involved in Raboral V-RG7 bait distribution;
a hypothetical ORV scenario is used to
illustrate use of the code.

New York, North Carolina, Pennsylvania,
Rhode Island, South Carolina, Tennessee,
Vermont, Virginia, and West Virginia) and
the District of Columbia (CDC 2001). Fishmeal polymer baits exist for effectively
delivering oral vaccines to raccoons (Olson et
al. 2000); These are Raboral V-RG7 baits
(Merial Limited, Athens, Georgia, USA). An
ORV program has been initiated to vaccinate
wild raccoons along the Appalachian Ridge to
stop the westward spread of this disease
(Foroutan et al. 2002, Slate et al. 2002, USDA
2001).
Economic uncertainty surrounds the
use of these baits. This is due in part to the
difficulty in determining regional costs of the
disease and in assessing potential savings
likely to result from an ORV program.
Although some data have been published
about post-exposure human prophylaxis (PEP)
and bait-distribution costs (see Foroutan et al.
2002, Kemere et al. 2002, Kreindel et al.
1998, Meltzer and Rupprecht 1998, Uaaa et
al. 1992), these studies lack systematic
projections of the relative costs and savings
likely with ORV.
Recently, Sterner (2002), Sterner and
Lorimer (2001), and Sterner and Tope (2002)
described an a priori approach to examining
the potential benefits and costs of wildlifedamage-management activities. Spreadsheet
software (Lotus7 1-2-37, 9.5 software, Lotus
Development, Cambridge, MA) was used to
compute iterative net savings (NSs) and
benefit-cost ratios (BCRs) linked with the use
of several wildlife management products (e.g.,
a rodenticide for vole control in alfalfa, a
commercial repellent for nuisance goose
management at golf courses). Fixed scenarios
were used to illustrate the possible losses and
prevention of losses likely from the use of
these products.
Multiple runs of the
programs, with 1-factor-changed-at-a-time
(e.g., product price, application rate,
persistence, area treated, amount of loss

COST-SAVINGS MODEL
Our model attributes the impact of
animal rabies in the U. S. economy to diverse
veterinary, medical, legal, and insurance
costs. The potential saving any of these costs
is viewed as the benefit of ORV.
Nature of Costs-Savings
Economists identify 3 categories of
costs and benefits: direct, indirect, and
induced (see Field 2001). Direct costs involve
actual monetary expenses attributable to
occurrence of rabies (e.g., pet vaccination
biologics, replacement price of a companion
animal, ORV bait, rabid animal quarantine,
pre- and post-exposure medical prophylaxis,
life insurance claim). The term indirect refers
to those tangential costs or savings that are
rabies-related expenses but which are
incidental to direct costs (e.g., lost work by
patients due to side effects of prophylaxis,
travel to medical facilities). Induced costs
also refer to a class of tangential costs or
savings that are due strictly to implementation
of ORV (e.g., labor costs to trap raccoons for
rabies surveillance, serum tests on raccoons to
monitor vaccine effectiveness).
Nature of Rabies and ORV
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(n Α $US/treatments),
PHBpublic health charges
(n Α $US/event for case investigations
and laboratory tests),
HDBinsured human death claims (n Α
$/death). [Note.BTo date, one human death
has been attributed to raccoon rabies.]
Potential net savings (NS) afforded by
raccoon variant ORV are viewed as C less the
ORV costs and any accident-related charges
(ACC):

Multiple variants of the rabies virus
occur in the U. S.: bat, canine coyote, arctic
fox, red fox, raccoon, and skunk (Childs
2002). These variants currently occupy
prescribed geographical regions, but variants
ascribed to different mammals occur
simultaneously (overlap) in certain regions
(Childs 2002). Any mammal can contract
rabies from a bite by an animal having these
variants; thus, it=s possible to have a rabid
raccoon occur in California even though the
raccoon variant virus has not been identified
there (e.g., contract rabies from a bat). While
ORV baits exist for coyote, fox, and raccoons,
oral vaccines for bat or skunk variant rabies
have yet to be developed (Johnston and
Tinline 2002).

NS = (C Α E) - (ORV + ACC).
where NS is total net savings, C is defined
above, E is the likely effectiveness benefit
(sero-positive conversion), ORV is the cost of
the baiting program and is dependent upon:
area (km2), bait cost ($US/bait), bait density
(baits/km2), mode-of-bait distribution [($US
fixed-wing
/rotary-wing
/ground
(%FW/%RW/%Gnd)], number of baitings (n),
and ACC is baiting-related accidents/injuries
(n Α $US/medical + $US/liability settlement).
[Note.BBait equipment is considered a prorated $US charge embedded with mode-ofbait distribution; currently such equipment
sells for about $3,500/unit and is
computerized to dispense baits at prescribed
rates on GIS-based azimuths; C. MacInnes,
personal communication, 2003). Obviously,
effectiveness is difficult to derive; it assumes
that returns on invested ORV monies are
related to the proportion of raccoons
successfully vaccinated as well as overall
suppression of the disease and curtailment of
future costs. These are not necessarily
equivalent or directly related; it is unknown
what portion of a population of raccoons need
to be vaccinated within an area to successfully
stop transmission or eliminate the disease.
Still, for current purposes, we have elected to
model this factor based upon the simple
percentage of raccoons hypothetically
vaccinated (i.e., 25, 50, 75, or 100%) --

Equations
The following equations define our
model:
C = [CAV + LV + CAR + LR + Q +
PreEP + PEP + PH + HD],
where C is the additive cost of a raccoon
variant rabies epizootic ($US). If ORV is
effective, these costs become potential savings
(S). Epizootic C is attributed to 9 main
variables:
CAVBCompanion animal vaccinations
(n Α $US/vaccination),
LVB livestock vaccinations
(n Α $US/vaccination),
CARBcompanion animal replacements
(n Α $US/animal for rabies-caused
deaths),
LRBlivestock replacements
(n Α $US/head for rabies-caused
deaths),
QBquarantine of suspected rabid animals
(n Α $US/event),
PreEPBhuman pre-exposure-prophylaxis
(n Α $US/vaccination),
PEPBhuman post-exposure-prophylaxis
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descriptions of the economic response
surfaces that would be attributed to
manipulations of specific variables substituted
for the parameters.

hypothetical effectiveness of preventing
rabies-incurred costs. Additionally, ACC is
considered to be zero ($0.00). To date, only 1
accidental dosing with the Raboral V-RG7
bait has occurred; an Ohio woman was dosed
while trying to retrieve a bait from her dog.
This incident was resolved in court; medical
assistance was waived by the plaintiff and no
liability was determined (R. Hale, personal
communication, 2003).
Finally, a BCR is derived using the
potential savings (S) in costs of the epizootic,
or the expected C:

Excel XP7 Code
Figure 1 presents the Excel XP7
output of potential NS and BCR indices.
Detailed code for computing several cells of
the spreadsheet is given in the caption;
formulas for remaining cells of the matrix are
readily derived by substitution.
As shown, input descriptors are listed
in Cells A2-A7 of the sheet; these request
information for area (km2), FW (%), RW (%),
Gnd (%) application, rabies cost ($US), and
number of baitings (n). Actual inputs for
these variables are entered in Cells B2-B7,
respectively. Formulas for computing BCRs
involving 5 designated bait prices [i.e., $0.90,
$1.10, $1.30, $1.50, and $1.70; Column D
(Cells D10-13, D15-18, D20-23, D25-28, and
D30-33, respectively)] combined with each of
4 bait densities [i.e., 50, 75, 100, and 125
baits/km2; Column E (Cells E10-13, E15-18,
E20-23, E25-28, and E30-33, respectively)]
and each of 4 sero-positive effectiveness
variables [i.e., 25% in Column F (Cells F1013, F15-18, F20-23, F25-28, and F30-33,
respectively); 50% in Column G (Cells G1013, G15-18, G20-23, G25-28, and G30-33,
respectively); 75% in Column H (Cells H013, H15-18, H20-23, H25-28, and H30-33,
respectively); and 100% in Column I (Cells
I10-13, I15-18, I20-23, I25-28, and I30-33,
respectively)] are programmed into the
intersecting cells of the code. A similar
matrix of NS values for these same inputs for

BCR = (C Α E) ) (ORV + ACC),
where C, E, ORV, and ACC are defined as
above. This ratio reflects potential future
savings in raccoon epizootic expenses due to
Raboral V-RG7 bait distribution. It is a
relative value, rendering area (km2) irrelevant.
A ratio of 1.0 refers to equality of ORV
expenses and potential S; values <1.0 or >1.0
indicate that benefits are likely to be smaller
or larger than ORV outlays, respectively.
ESTIMATING ECONOMIC EFFECTS
OF ORV
Excel XP7 code was prepared to
compute and graph BCR and NS indices
associated with ORV bait distributions. As
implied in the model, 6 parameters are viewed
to determine the potential costs of Raboral VRG7 bait distributions: (1) area of bait
application (km2), (2) bait price ($/bait), (3)
bait density (baits/km2), (4) bait application
frequency (n), (5) mode of bait distribution
(km2 FW, RW, and Gnd), and (6)
effectiveness (% sero-positive conversion of
wild raccoons). Of course, the probable cost
(C) of the epizootic (or potential S) must be
input. Induced costs of surveillance and
testing raccoons in ORV areas were not
programmed. Iterative, 1-variable-changedat-a-time runs of this code allowed plots and
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Figure 1. Schematic view of Excel XP7 output used to perform net savings and benefit-cost ratio estimates. Selected cell formulas are:
F10=($B$6*$F$9)/((($D$10*E10*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7),
I33=($B$6*$I$9)/((($D$30*E33*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7),
M10=($B$6*$M$9)-((($K$10*L10*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7),
P3 =($B$6*$P$9)-((($D$30*L33*$B$2)+$B$2*($B$3*8.5+$B$4*33.3+$B$5*15.8))*$B$7).

A
Area sq. km
%FW
%RW
%ATV
Epidemic cost
Baitings

B
29021
100%
0%
0%
$40,000,000
1

C* D
1
2
3
4
5
6
7
8

E

Benefit-Cost
Cost/
Bait

F

G

H

I

Ratios

5.43
3.79
2.91
2.36

3.69
2.53
1.93
1.56

K

L

M

N

O

P

Net Savings

Bait
Sero+ Conversion Rates
Density
25%
50% 75%
100%
50
6.44
12.88 19.32 25.76
75
4.53
9.07 13.60 18.14
100
3.50
7.00 10.49 13.99
125
2.85
5.70 8.54
11.39

9
10 $0.90
11
12
13
14
15 $1.10 50
16
75
17
100
18
125
19
20 $1.30
50
9 9
9
24
25 $1.50
50
9
9
29
30 $1.70 50
31
75
32
100
33
125
* Denotes row number; this column is blank in code.

J

10.85
7.57
5.82
4.72

7.37
5.07
3.86
3.12

16.28
11.36
8.72
7.08

11.06
7.60
5.79
4.68

21.71
15.15
11.63
9.44

14.74
10.13
7.72
6.24
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Cost/
Bait

Bait
Sero+ Conversion Rates
Density
25%
50%
50
$8,447,377
$18,447,377
75
$7,794,404
$17,794,404
100
$7,141,432
$17,141,432
125
$6,488,459
$16,488,459

75%
$28,447,377
$27,794,404
$27,141,432
$26,488,459

100%
$38,447,377
$37,794,404
$37,141,432
$36,488,459

$1.10

50
75
100
125

$1.30
9

50
9

$1.50
9

50
9

$0.90

50
75
100
125

$8,157,167
$7,359,089
$6,561,012
$5,762,934

$18,157,167
$17,359,089
$16,561,012
$15,762,934

$28,157,167
$27,359,089
$26,561,012
$25,762,934

$38,157,167
$37,359,089
$36,561,012
$35,762,934

$7,286,537
$6,053,144
$4,819,752
$3,586,359

$17,286,537
$16,053,144
$14,558,563
$13,586,359

$27,286,537
$26,053,144
$24,819,752
$23,586,359

$37,286,537
$36,053,144
$34,819,752
$33,586,359

13, P15-18, P20-23, P25-28, and P30-33,
respectively), respectively. The actual prices
for mode of bait distribution (i.e., FW
$8.62/km2, RW $33.30/km2, and Gnd
$15.80/km2) are coded into the formulas;
these costs were derived from published
literature (see Kemere et al. 2002; Foroutan et
al. 2002). Expenses for machines to dispense
baits were assumed to be pro-rated into the
mode-of-bait distribution costs (i.e., cost of
FW, RW, Gnd; $US/km2).
Table 1 provides a mathematical
example of a specific calculation for cost, net
saving, and benefit cost ratio.

bait prices, bait densities, and sero-positive
effectiveness variables occurs in Column K
[i.e., $0.90, $1.10, $1.30, $1.50, and $1.70;
(Cells K10-13, K15-18, K20-23, K25-28, and
K30-33, respectively), Column L [i.e., 50, 75,
100, and 125 baits/km2; Cells L10-13, L15-18,
L20-23, L25-28, and L30-33, respectively)
and sero-positive effectiveness variables in
Columns M (i.e., 25% in Cells M10-13, M1518, M20-23, M25-28, and M30-33,
respectively), N (i.e., 50% in Cells N10-13,
N15-18, N20-23, N25-28, and N30-33,
respectively), O (i.e., 75% in Cells O10-13,
O15-18, O20-23, O25-28, and O30-33,
respectively), and P (i.e., 100% in Cells P10-

Table 1. Mathematical Example
Area = 1,000 km2
FW 40% ($8.62/km2), RW 20% ($33.30/km2), Gnd 40% ($15.80/km2)
Epizootic cost = $1,000,000.00
Number of Baitings = 3 repeats
Cost/bait = $0.90
Bait Density = 50/km2
Sero-positive conversion among raccoons = 0.50
C
NS

=
=
=
=

=
=
=
BCR =
=
=

(Rabies-incurred Cost)
$1,000,000.00
[(Total Rabies Cost Α Sero+ Effectiveness) - (ACC + ORV)]
[($1,000,000 Α 0.50) - {[$0.00 accidents] + {[($0.90 bait price Α 50 baits/km2 Α
1000 km2) + (1000 km2 (0.40 FWΑ $8.62) + 1000 km2 (0.20 RW Α $33.30) + 1000
km2 (0.40 Gnd Α $15.80) Α 3 bait distributions]
[($500,000) - ($0.00 + [($45,000) + ($7000 + $6660 + $6320)] Α 3}
[($500,000) - ($194,940)]
$305,060
[(Total Rabies Cost Α Sero+ Effectiveness) ) (ACC + ORV)]
[($500,000) ) ($0.00 + $194,060)]
+2.56 (i.e., savings in costs of raccoon rabies epizootic are more than double the
expenses of implementing ORV with half of the raccoon population vaccinated).
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cost of the HRIG (biologic) alone varied between
$632 and $3,435 (median value of $1,646), but
when physician and hospital emergency-room
charges were added, the direct per-patient cost
ranged from a low of $1,038 to a high of $4,447
(i.e., median PEP of $2,376). Using area and
population data for Pennsylvania (Rand McNally
2002), converting this change in PEP incidence
to 12,281,074 population for Pennsylvania yields
an increase of 3,439 PEPs (17/100,000 vs
45/100,000 or a shift of 28:100,000) and
expected median-based PEP costs of
$8,171,064/year. Assuming that a raccoon rabies
epizootic lasts 2 years (Meltzer 1996), direct PEP
expenses for Pennsylvania would exceed $16
million. Add to this other direct costs for
increased pet vaccinations (e.g., $5 million/year
or $10 million for the epizootic), increased PH
and Q expenses (e.g., $5 million/year or $10
million for the epizootic), not to mention indirect
costs such as lost wages, travel expenses, and
child care expenses borne by patients (e.g., $2
million/year or $4 million for the epizootic), and
a total statewide cost of $40 million is easily
justified.

A Scenario
An attempt is made to prevent a raccoon
rabies outbreak in parts of Pennsylvania from
spreading throughout the state. A focal point of
rabid animals has been identified in several
clustered counties. Raboral V-RG7 baits are to
be applied over a fourth of the state radiating out
from the cluster to prevent the epizootic from
reaching the remaining counties.
Raccoon Rabies Potential Savings.BA
key input needed to compute BCRs and NSs is
the expected costs incurred due to the
epizooticBthe potential savings from ORV. Our
code requires input based on C ($US). For
current calculations, we have used a single
valueB$40 million. While this is a hypothetical
C or S, it can be justified based upon empirical
data.
Increased PEP and pet vaccinations are
the major economic components of any rabies
epizootic (Meltzer 1996). Kriendel et al. (1998)
surveyed the costs of medical PEPs during a
1995 epizootic of raccoon rabies in
Massachusetts, and reported that the rate of
medical use for Human Rabies Immune Globulin
(HRIG) went from a baseline of 17/100,000 to
45/100,000 citizens between 1991 and 1995. The

Table 2. Input variables used for Raboral V-GR7 scenario projections.
Variable
Area baited (km2)
Bait price ($US/bait)
Bait density (n/km2)
Number of baitings (n)
Rabies epizootic costs/savings ($US)
Mode of application (% of km2)c
FW = $ 8.62/km2
RW = $33.30/km2
Gnd = $15.80/km2

Number of Levels
1
5
4
2
1
6

Inputs
29,021a
0.90, 1.10, 1.30, 1.50, 1.70
50, 75, 100, 125
1, 3
40,000,000
FW, RW, Gnd
100, 0, 0
0, 100, 0
0, 0, 100
50, 50, 0
50,
0, 50
0, 50, 50
25, 50, 75, 100

Effectiveness (Sero+ %)
4
One-fourth the area of PA.
b
Note.-- Bait-drop equipment included with lease rate for aircraft; FW cost from Kamere et al. (2002), RW and Gnd
cost from Foroutan et al. (2002).
c
Although 161,700 combinations of the Amode@ settings are possible, we present data for only 6 combinations of
a
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these variables.

distribution involving FW aircraft for the entire
area.
Lower bait prices ($0.90 to $1.70), lesser
bait densities (50/km2 to 125/km2), fewer bait
applications (1 vs. 3), and greater use of the
cheaper FW mode of bait distribution yielded
greater NS and higher BCR indices. Regarding
the iterative runs involving mode-of-bait
distribution, increasingly positive NS and BCR
indices occurred as the mode involved less RW
or Gnd coverage relative to FW aircraft (i.e., RW
< Gnd also yielded transitivity). This same effect
of inversely higher NS and BCR values was also
observed for the dual modes of distributions (i.e.,
RW-Gnd, RW-FW, and FW-Gnd yielded lower
NS and BCR values, respectively).
These results readily show how economic
impacts are dependent upon the relative price
structure involved in ORV. Bait price, bait
density, mode of distribution, and repeated
baiting interact to determine current ORV cost
effectiveness. At present, production of Raboral
V-RG7 baits are labor intensive and involve
individual preparation. Sale to federal sources
(United States Department of Agriculture 2001)
is set at $1.27/baitBa price associated with BCRs
>3.0 for all RW, Gnd, and FW bait distributions
involving a single application. The required
density of baits needed to successfully vaccinate
a sufficient segment of a raccoon population so
as to create a rabies-free zone (Abarrier@) or to
Aeliminate@ the disease is unknown. This
question is receiving intense research interest
(see Kemere et al. 2002, Slate et al. 2002). All of
our computer runs involving #125 baits/km2
produced >2.0 BCRs at bait prices <$1.30.

ORV Inputs.B As mentioned, five bait
price, four bait density, and four seropositive
effectiveness variables are pre-coded into the
analysis (Table 2). A single input was used for
the area baited (29,021 km2B1/4 the state of PA)
and for the potential cost savings with ORV ($40
million). Dual inputs were used for the required
number of baitings needed to suppress the
outbreak (1 and 3). Six mode-of-bait distribution
combinations
were
used
(RWB100%,
GndB100%, FWB100%, RW-GndB50% each,
RW-FWB50% each, and FW-GndB50% each).
Data Analysis
Each iteration of the code (mode-of-bait
distribution) produced 80 NS and 80 BCR
estimates (see Figure 1); thus, the six iterative
runs yielded a total of 960 separate NS and BCR
indices. These were plotted to show the threedimensional response surface effects associated
with the ORV variables.
RESULTS AND DISCUSSION
Scenario
For a single baiting involving complete
bait distributions via single modes of delivery
(i.e., RW, Gnd, or FW), NS values ranged from
2,866,638 to 38,447,377 (Figure 2a) and BCR
values ranged from 1.40 to 25.76 (Figure 2b),
respectively. The need for 3 repeat baitings to
suppress the epizootic via these sole modes of
delivery yielded NSs between -$11,400,085 and
+$35,342,130 (Figure 3a) and BCRs between
0.47 and 8.59 (Figure 3b), respectively. The
greatest NS ($3.5 to 38.4 million) and BCR (1.56
to 25.76) estimates occurred for a one-time bait
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Figure 2. A 3-dimensional graph of the response surface for (a) potential net savings and (b)
potential benefit-cost ratios showing the effects of 1 and 3 repeated baitings with 100% RW, Gnd,
and FW mode-of-bait distributions over 29,021 km2.
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Figure 3. A 3-dimensional graph of the response surface for (a) potential net savings and (b)
potential benefit-cost ratios showing the effects of 1 and 3 repeated baitings with 50-50% RW-Gnd,
RW-FW, and FW-Gnd mode-of-bait distributions over 29,021 km2.
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westward spread of the disease using Raboral VRG7 (Merial Limited, Athens, Georgia, USA)
baits. The zone was viewed to encompass
102,605 km2 and parallel areas along western
parts of the Appalachian Ridge. A benefit-cost
approach was used that assumed a 20-year period
for creation and maintenance of the barrier.
Estimates of diverse surveillance, medical,
veterinary, and evaluation costs were compared
to estimates of bait-application costs under four
models, with potential savings tied to reduced
need for these outlays west of the barrier. Four
models specified either a 40.2 (Models A and B)
or a 127.1 (Models C and D) km/yr spread of
raccoon variant rabies with or without the
potential costs for epizootic-induced veterinary
prophylaxis of domestic animals, respectively.
Under these scenarios, program costs totaled
$95.7 million; whereas, net benefits (discounted
at 7%/yr) ranged between $48 and $496 million,
depending upon whether bait applications
continued unchanged or were scaled back (larger
net benefits) after initial set up of the zone.
Sensitivity analyses yielded mean (SD) net
benefits of 202 (4.10), 109 (4.11), 496 (4.07, and
313 (4.07) for Models A, B, C, and D,
respectively.

Approach
Our scenario results demonstrate the
utility of using spreadsheet projections to
evaluate potential economic impacts of Raboral
V-RG7 bait distributions for containing or
eliminating raccoon variant rabies in the Eastern
U. S. Despite numerous assumptions, we
contend that our iterative projections of NS and
BCR indices reduce the economic uncertainty
associated with ORV. The approach affords a
quick, relatively inexpensive tool for modeling
diverse ORV scenarios. The graphical and
tabular displays of a range of NS and BCR
indices for variables involved in ORV afford
decision heuristics to be set up that ensure
improved applications of the technology (e.g.,
keeping RW- and Gnd-based bait distributions to
<30% of the total area, limit bait densities to
<75/km2). This approach shows how bait price,
bait density, bait frequency, and bait
effectiveness relate to overall cost effectiveness
of ORV.
A major implication of our scenario
analysis is that more accurate estimates of the
total costs which raccoon variant rabies exert on
the U. S. economy are sorely needed. These
costs are critical to any determination of potential
ORV benefits.
Also, realistic economic
approaches to determining the pay-back scheme
for wide-area ORV strategies need to be
identified. Empirical studies of not only direct,
but indirect and induced costs/savings, associated
with raccoon variant ORV will offer more
precision for future analyses; whereas, pro-rated,
multi-year benefits from ORV may more
accurately characterize these returns on
investments (Meltzer 1996). While our use of a
two-year, $40 million cost-savings value for a
Pennsylvania focal outbreak was intentionally
conservative, this scenario is a simple Asnapshot@ of how ORV benefits may impact future
economies. Still, even this showed that 1 or 3
bait distributions over one-fourth of the state
could yield significant savings and multiple
returns on expenses assuming a specific bait
price, density, and mode of distribution.
Kemere et al. (2002) modeled the
economic benefits of creating a hypothetical zone
of vaccinated raccoons as a Abarrier@ to the

CONCLUSIONS
Using a raccoon rabies epizootic
suppression scenario for parts of Pennsylvania
and a modest epizootic cost estimate of $40
million, ORV was projected to yield NS values
>2.8 million and BCR values >1.4, respectively.
If numerous assumptions are made, Excel7 XP
software can be used to make projections of NS
and BCR associated with ORV. Using the code
we have generated, graphical and tabular displays
of the response surfaces for key variables and
numerous scenarios can be performed quickly.
The approach offers a useful analytical tool for
identification of critical cost thresholds for the
myriad of cost factors that affect ORV. The
potential for simple heuristics to be devised that
govern profitable/non-profitable applications of
ORV should be a future asset.
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